
|Videos|April 29, 2022
Riad Sherif, CEO of Oculis, gives a company update on clinical trials, financing and other items in the pipeline
Author(s)Kassi Filkins
Riad Sherif, MD, CEO of Oculis, gives a company update on clinical trials for products in DME, ocular surgery, and more; plus, growing products in glaucoma treatments, team and financing updates.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Sharper vision starts here
2
Oculis to launch PIONEER trials for privosegtor in acute optic neuritis and NAION
3
iOpeners: Zubair Ansari, MD, shares his global health journey with Nicole Bajic, MD
4
Study finds retinal progenitor cell injections improve outcomes in rat model of diabetic retinopathy
5